Thu. 09/27
Session T.3 / KTS Katharinenhall / 02.00 - 03.30 pm
CV Stem Cells
Chairman 1: W. Sherman, New York, USA / Chairman 2: D. Kong, Tianjin, China
| 02.00 - 02.15 pm | O19 | A new strategy to transform bone marrow stem-cells into venous endothelial cells F. Schlegel, Leipzig, Germany |
| 02.15 - 02.30 pm | O20 | Intra-Myocardial Homing of Adult Stem Cells in a Goat Model: Glandular vs. Mesenchymal Stem Cells N.W. Guldner, Luebeck, Germany |
| 02.30 - 02.45 pm | O21 | Transplantation of parthenogenetic embryonic stem cells for treatment of myocardial infarction Y. Liu, Tianjin, China |
| 02.45 - 03.00 pm | O22 | Identification of cardioprotective CD4+AT2R+ T cell subpopulation in response to ischemic heart injury A. Skorska, Rostock, Germany |
| 03.00 - 03.15 pm | O23 | Influence of the stimulation of AT2R via its agonist Compound 21 on the characteristics of murine CD117+ bone marrow stem cells M. Ludwig, Rostock, Germany |
| 03.15 - 03.30 pm | O24 | Therapeutically relevant characteristics of a ResQ 60 BMC-prepared cell product from human sternal bone marrow depend on stem cell content in vitro and in vivo C.A. Lux, Rostock, Germany |